Ceftriaxone disodium salt hemiheptahydrate

규격

104376-79-6CAS 번호

tetrasodium;bis((6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate);heptahydrateIUPAC 명칭

C36H46N16Na4O21S6화학식

1323.2 g/mol분자량

Ceftriaxone disodium salt hemiheptahydrate; 104376-79-6; DTXSID5045887; Ceftriaxone Sodium Hemiheptahydrate; Ro 13-9904; Ceftriaxone sodium hydrate; tetrasodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;heptahydrate; Ceftriaxone sodium (USP); DTXCID001477151; CAS-104376-79-6; UNII-023Z5BR09K; Rocephin (TN); Ceftriaxone sodium [USAN:USP:JAN]; Ceftriaxone sodium CRS; NCGC00095007-01; MSK10010NaW; ceftriaxone sodium heptahydrate; SCHEMBL719571; CHEBI:3514; orb1309336; orb3141374; CHEMBL6067656; CEFTRIAXONE SODIUM [USAN]; CEFTRIAXONE SODIUM [VANDF]; CEFTRIAXONE SODIUM [MART.]; CEFTRIAXONE SODIUM [USP-RS]; Ceftriaxone sodium hydrate (JP18); Tox21_111386; AKOS040733860; Tox21_111386_1; CEFTRIAXONE SODIUM [ORANGE BOOK]; CEFTRIAXONE SODIUM HYDRATE [JAN]; CEFTRIAXONE SODIUM [EP MONOGRAPH]; NCGC00263961-02; CEFTRIAXONE DISODIUM TRIHEMIHYDRATE; CEFTRIAXONE SODIUM [USP MONOGRAPH]; SODIUM CEFTRIAXONE HEMIHEPTAHYDRATE; D00924; ROCEPHIN KIT COMPONENT CEFTRIAXONE SODIUM; CEFTRIAXONE (AS DISODIUM HEMIHEPTAHYDRATE); CEFTRIAXONE SODIUM SESQUATERHYDRATE [WHO-DD]; CEFTRIAXONE DISODIUM SALT HEMIHEPTAHYDRATE [MI]; Q27231488; (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), disodium salt, sesquaterhydrate; (6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-8-OXO-3-(((1,2,5,6-TETRAHYDRO-2-METHYL-5,6-DIOXO-AS-TRIAZIN-3-YL)THIO)METHYL)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7SUP(2)-(Z)-(O-METHYLOXIME), DISODIUM SALT, SESQUATERHYDRATE; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-8-OXO-3-(((1,2,5,6-TETRAHYDRO-2-METHYL-5,6-DIOXO-1,2,4-TRIAZIN-3-YL)THIO)METHYL)-, DISODIUM SALT, (6R-(6.ALPHA.,7.BETA.(Z)))-, HYDRATE (2:7); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, (6R-(6alpha,7beta(Z)))-, hydrate (2:7); 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, hydrate (2:7), (6R-(6alpha,7beta(Z))-; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, disodium salt, hydrate (2:7), (6R,7R)-; Sodium (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-5,6-dihydro-2H-1,2,4-triazin-1-id-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate--water (4/2/7)동의어